Objectives: To determine the level of brain natriuretic peptide (NT-proBNP) in the blood and the level of excretion of catecholamines (epinephrine and norepinephrine) in daily urine in patients with SLE. This evidence concerns the gene NPPB and systemic lupus erythematosus.